Aquestive Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AQST and other ETFs, options, and stocks.

About AQST

Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. 

CEO
Daniel Barber
CEODaniel Barber
Employees
142
Employees142
Headquarters
Warren, New Jersey
HeadquartersWarren, New Jersey
Founded
2004
Founded2004
Employees
142
Employees142

AQST Key Statistics

Market cap
728.26M
Market cap728.26M
Price-Earnings ratio
-8.70
Price-Earnings ratio-8.70
Dividend yield
Dividend yield
Average volume
2.52M
Average volume2.52M
High today
$6.40
High today$6.40
Low today
$5.83
Low today$5.83
Open price
$6.08
Open price$6.08
Volume
3.32M
Volume3.32M
52 Week high
$7.55
52 Week high$7.55
52 Week low
$2.12
52 Week low$2.12

Stock Snapshot

With a market cap of 728.26M, Aquestive Therapeutics(AQST) trades at $6.08. The stock has a price-to-earnings ratio of -8.70.

During the trading session on 2025-11-06, Aquestive Therapeutics(AQST) shares reached a daily high of $6.40 and a low of $5.83. At a current price of $6.08, the stock is +4.3% higher than the low and still -5.0% under the high.

Trading activity shows a volume of 3.32M, compared to an average daily volume of 2.52M.

Over the past 52 weeks, Aquestive Therapeutics(AQST) stock has traded between a high of $7.55 and a low of $2.12.

Over the past 52 weeks, Aquestive Therapeutics(AQST) stock has traded between a high of $7.55 and a low of $2.12.

AQST News

Simply Wall St 21h
Retail investors who have a significant stake must be disappointed along with institutions after Aquestive Therapeutics, Inc.'s market cap dropped by US$77m

Advertisement Key Insights Significant control over Aquestive Therapeutics by retail investors implies that the general public has more power to influence man...

Retail investors who have a significant stake must be disappointed along with institutions after Aquestive Therapeutics, Inc.'s market cap dropped by US$77m

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own AQST. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.